Structure-Activity Relationship and Molecular Docking-Guided Development of Andrographolide-Based Antidiabetic Agents. Drug Discovery and Molecular Docking (DDMD), [S. l.], p. 140–156, 2026. Disponível em: https://ddmdpress.com/1/article/view/31. Acesso em: 30 aug. 2026.